Adverum Biotechnologies Inc.
12/11/2025 | Press release | Distributed by Public on 12/12/2025 05:02
Notice of Effectiveness (Form EFFECT)
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 11, 2025 |
| Accession Number: | 0001193125-25-312780 | ||||||
| Submission Type: | POS AM | ||||||
|
|||||||
Adverum Biotechnologies Inc. published this content on December 11, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on December 12, 2025 at 11:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]